Circadiance has acquired the SmartMonitor and NeoPAP product lines from Philips, which includes the infant apnea monitoring technologies and infant positive airway pressure (PAP) technologies associated with these brands, according to a company news announcement.
Circadiance is best known for its line of SleepWeaver soft cloth CPAP masks for positive airway pressure treatments for conditions such as obstructive sleep apnea. The acquisition of the Philips pediatric line and related intellectual property allow Circadiance to enter the global pediatric respiratory market, the company said.
“Home infant cardiorespiratory monitoring is an established market dominated by SmartMonitor’s proven technology which offers at-risk infants a smooth transition from hospital to home,” said David Groll, CEO of Circadiance. “NeoPAP represents the future of respiratory care in neonatal patients with respiratory distress syndrome. It’s an exciting combination that we intend to leverage with future innovation.”
Both Circadiance and Philips expect the transition of the product lines to be completed by the end of this week, according to the company news announcement.
